In cancer, the normal functioning of cell cycle checkpoints is often disrupted. This allows cells with damaged DNA to continue dividing, leading to the accumulation of mutations and the development of tumors. Mutations in genes that encode checkpoint proteins, such as TP53 (which encodes p53), can lead to checkpoint failure and contribute to cancer progression.
